Expression of the Classical and Nonclassical HLA Molecules in Breast Cancer (Q37394717)

20 August 2017

Expression of the Classical and Nonclassical HLA Molecules in Breast Cancer (English)

1 reference

20 August 2017

1 reference

Gisela Bevilacqua Rolfsen Ferreira da Silva

1

1 reference

20 August 2017

Tarsia Giabardo Alves Silva

2

1 reference

20 August 2017

Roberta Aparecida Duarte

3

1 reference

20 August 2017

Nicolino Lia Neto

4

1 reference

20 August 2017

Hélio Humberto Angotti Carrara

5

1 reference

20 August 2017

Eduardo Antônio Donadi

6

1 reference

20 August 2017

Maria Alice Guimarães Gonçalves

7

1 reference

20 August 2017

Edson Garcia Soares

8

1 reference

20 August 2017

Christiane Pienna Soares

9

1 reference

20 August 2017

language of work or name

1 reference

2 December 2013

1 reference

International Journal of Breast Cancer

20 August 2017

1 reference

20 August 2017

2013

1 reference

20 August 2017

250435

1 reference

Creative Commons Attribution 3.0 Unported

20 August 2017

start time

1 January 2013

1 reference

April 2022 Public Data File from Crossref

Creative Commons Attribution 3.0 Unported

0 references

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Human leukocyte antigen G expression in breast cancer: role in immunosuppression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Triple-negative breast cancer: clinical features and patterns of recurrence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Mini-review: overcoming tumor-intrinsic resistance to immune effector function.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

MHC class I down-regulation: tumour escape from immune surveillance? (review).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Does the immune system see tumors as foreign or self?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Know thy neighbor: stromal cells can contribute oncogenic signals

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

The functionality of HLA-G is emerging

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Prognostic factors and treatment decisions in axillary-node-negative breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

HLA-G gene activation in tumor cells involves cis-acting epigenetic changes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Analysis of HLA-E expression in human tumors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Selective expression of HLA-G in malignant and premalignant skin specimens in kidney transplant recipients.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Breast cancer as a global health concern

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

CpG motifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3864140

Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer

2 October 2018

1 reference

12 December 2020

Altered expression of HLA class I antigens in breast cancer: association with prognosis

1 reference

12 December 2020

Biochemical analysis of HLA class I subunits expression in breast cancer tissues

1 reference

12 December 2020

HLA-E surface expression is independent of the availability of HLA class I signal sequence-derived peptides in human tumor cell lines

1 reference

12 December 2020

Analysis of human lymphocyte antigen class I expression in gastric cancer by reverse transcriptase-polymerase chain reaction

1 reference

12 December 2020

The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators

1 reference

12 December 2020

Altered expression of nonclassical HLA class Ib antigens in human renal cell carcinoma and its association with impaired immune response

1 reference

12 December 2020

HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma

1 reference

12 December 2020

MHC class I negative phenotype of disseminated tumor cells in bone marrow is associated with poor survival in R0M0 breast cancer patients

1 reference

12 December 2020

HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients

1 reference

12 December 2020

HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract

1 reference

12 December 2020

Analysis of HLA-G expression in breast cancer tissues

1 reference

12 December 2020

Establishment of a monoclonal anti-pan HLA class I antibody suitable for immunostaining of formalin-fixed tissue: unusually high frequency of down-regulation in breast cancer tissues

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/250435

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

24363939

1 reference